Latest News & Updates
Breaking News
16 hours ago
Pharma Now Editorial Team
ReproNovo Achieves First Dosing Milestone in EU Phase 2 NORDIC Trial for RPN-002 in ART
Pharma Now Editorial Team
Avantor Secures Exclusive Sartorius Filter Paper Distribution Rights Across India
Pharma Now Editorial Team
Other trending news you may like to read
Novartis Acquires Myricx Bio in $1.5bn Deal to Add NMTi ADC Payload Platform
Novartis acquires Myricx Bio for up to $1.5bn, adding an NMTi ADC payload platform targeting resistance to current conjugate classes.
Pharma Now Editorial Team
ReproNovo Achieves First Dosing Milestone in EU Phase 2 NORDIC Trial for RPN-002 in ART
ReproNovo doses first participant in EU Phase 2 NORDIC trial of RPN-002, an oral oxytocin receptor antagonist targeting uterine contractility in ART.
Pharma Now Editorial Team
Avantor Secures Exclusive Sartorius Filter Paper Distribution Rights Across India
Avantor becomes exclusive India distributor for Sartorius filter papers, reshaping consumable sourcing for QC labs and pharma manufacturers.
Pharma Now Editorial Team
WHO Adds First Ebola Bundibugyo Diagnostic Test to Emergency Use Listing Amid DRC Outbreak
WHO lists first molecular diagnostic for Ebola Bundibugyo virus under EUL, seven weeks after PHEIC declaration over the DRC outbreak.
Vaibhavi M.
